Provided by Tiger Trade Technology Pte. Ltd.

Oculis

13.18
+0.09500.73%
Post-market: 13.250.0700+0.53%19:30 EDT
Volume:150.39K
Turnover:1.97M
Market Cap:813.63M
PE:-7.68
High:13.25
Open:13.10
Low:12.87
Close:13.09
52wk High:34.48
52wk Low:10.52
Shares:61.73M
Float Shares:53.44M
Volume Ratio:0.86
T/O Rate:0.28%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.7151
EPS(LYR):-2.3888
ROE:-43.70%
ROA:-24.95%
PB:2.98
PE(LYR):-5.52

Loading ...

Oculis Holding AG reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 12

Oculis Holding Q1 EPS $(0.63) Misses $(0.49) Estimate, Sales $266.845K Miss $320.000K Estimate

Benzinga Earnings
·
May 12

Oculis Reports Strong Liquidity in Q1 2026 Unaudited Results

TIPRANKS
·
May 12

Switzerland's Oculis Q1 net loss narrows, cash rises

Reuters
·
May 12

Press Release: Oculis Reports Q1 2026 Financial Results and Provides Company Update

Dow Jones
·
May 12

aTyr Pharma Provides Regulatory and Clinical Update for Efzofitimod in Pulmonary Sarcoidosis Following FDA Type C Meeting

GlobeNewswire
·
May 12

Does TransMedics (TMDX) Revenue Growth And OCS Adoption Clarify Or Complicate Its Profitability Path?

Simply Wall St.
·
May 09

Oculis Holding (OCS) Receives a Buy from H.C. Wainwright

TIPRANKS
·
May 08

Oculis Announces Agreement with FDA on a Special Protocol Assessment (SPA) for Optic Neuritis Registrational Trial

GlobeNewswire
·
May 07

Earning Preview: Oculis revenue is expected to decrease by 3.77%, and institutional views are bullish

Earnings Agent
·
May 04

Oculis Nears Key Milestone as Phase 3 OCS-01 Eye Drop Trial in Diabetic Macular Edema Completes

TIPRANKS
·
May 03

Oculis to Present at Upcoming Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting

GlobeNewswire
·
May 01

Oculis to Present at Upcoming Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting

GlobeNewswire
·
May 01

Orient Securities: Inference Expands New Frontiers for OCS, ASIC Liquid Cooling Becoming Standard

Stock News
·
Apr 29

Analysts Offer Insights on Healthcare Companies: MiMedx Group (MDXG) and Oculis Holding (OCS)

TIPRANKS
·
Apr 28

Oculis Advances Targeted Dry Eye Drug Licaminlimab Into Late-Stage Testing

TIPRANKS
·
Apr 26

Alphabet's Eighth-Generation TPU Launch Seen Benefiting Optical Modules, OCS, and Liquid Cooling Supply Chains

Stock News
·
Apr 24

Oculis Publishes Invitation to the Annual General Meeting

GlobeNewswire
·
Apr 22

Morning Briefing Highlights: Experience Economy in Full Swing, Service Consumption Enters New Phase

Stock News
·
Apr 21

Oculis Buy Rating Reiterated on De-Risked Phase 3 DIAMOND Program and Blockbuster Potential of Topical DME Therapy OCS-01

TIPRANKS
·
Apr 21